staurosporine has been researched along with pf 3758309 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Cheng, M; Guo, J; Hao, C; Huang, W; Jiang, X; Li, F; Li, X; Song, S; Wang, J; Wang, K; Yan, Z; Zhao, D | 1 |
| Cheng, M; Gu, J; Guo, J; Hao, C; He, Z; Liu, Y; Pang, Y; Wang, T; Wu, T; Yin, W; Zhang, K; Zhao, D; Zheng, J; Zhu, M | 1 |
| Chen, Y; Fang, X; Gao, Y; Hua, Y; Huang, C; Li, H; Liu, H; Lu, S; Lu, T; Wang, C; Wang, M; Wang, Z; Zhang, M; Zhang, T; Zhang, Y; Zhu, L | 1 |
3 other study(ies) available for staurosporine and pf 3758309
| Article | Year |
|---|---|
Development of 2, 4-diaminoquinazoline derivatives as potent PAK4 inhibitors by the core refinement strategy.
Topics: A549 Cells; Cell Cycle; Cell Movement; Dose-Response Relationship, Drug; Humans; Molecular Docking Simulation; Molecular Structure; p21-Activated Kinases; Protein Kinase Inhibitors; Quinazolines; Structure-Activity Relationship | 2017 |
Synthesis, bioconversion, pharmacokinetic and pharmacodynamic evaluation of N-isopropyl-oxy-carbonyloxymethyl prodrugs of CZh-226, a potent and selective PAK4 inhibitor.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HCT116 Cells; Humans; Liver; Male; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Neoplasms, Experimental; p21-Activated Kinases; Piperazines; Prodrugs; Protein Kinase Inhibitors; Rats; Rats, Wistar; Structure-Activity Relationship | 2020 |
Design and synthesis of 1H-indazole-3-carboxamide derivatives as potent and selective PAK1 inhibitors with anti-tumour migration and invasion activities.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Chemistry Techniques, Synthetic; Drug Design; Humans; Hydrophobic and Hydrophilic Interactions; Indazoles; Inhibitory Concentration 50; Neoplasm Invasiveness; p21-Activated Kinases; Protein Kinase Inhibitors | 2020 |